Literature DB >> 2305833

IL-2 mRNA expression in Tac-positive malignant lymphomas.

M Peuchmaur1, D Emilie, M C Crevon, P Solal-Celigny, M C Maillot, G Lemaigre, P Galanaud.   

Abstract

Expression of the IL-2 receptor (Tac antigen/CD25) is documented in malignant lymphomas. Because IL-2 is a major lymphocyte growth factor, an IL-2-dependent growth could be involved in the proliferation of Tac-positive lymphomas. Indeed such a mechanism has been demonstrated experimentally for the growth of T-cell lines. To investigate this point in human lymphomas, we used in situ hybridization to analyze the expression of the IL-2 gene in 20 non-Hodgkin's lymphomas, among which 12 expressed the IL-2 receptor. Nine of these were anaplastic large cell lymphomas expressing the Ki-1-related antigen. We here show that IL-2-producing cells are present in all the lymphomas we analyzed. As a mean, there is no significant difference in the percentage of IL-2-producing cells between Tac-positive and -negative lymphomas. However, the level of IL-2 production is highly heterogeneous in both groups, and the highest density of IL-2-producing cells was observed in 2 Tac-positive lymphomas. Simultaneous detection of cellular antigens and of IL-2 mRNA demonstrates that IL-2 is produced by reactive T cells rather than by tumor cells. These results suggest that if IL-2 is involved in the growth of Tac-positive lymphomas, it acts as a paracrine, rather than an autocrine, factor.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2305833      PMCID: PMC1877409     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  34 in total

1.  Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy.

Authors:  M E Kadin; D Sako; N Berliner; W Franklin; B Woda; M Borowitz; K Ireland; A Schweid; P Herzog; B Lange
Journal:  Blood       Date:  1986-11       Impact factor: 22.113

2.  Interleukin-2 augments natural killer cell activity.

Authors:  C S Henney; K Kuribayashi; D E Kern; S Gillis
Journal:  Nature       Date:  1981-05-28       Impact factor: 49.962

3.  Simultaneous in situ detection of viral RNA and antigens.

Authors:  M Brahic; A T Haase; E Cash
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

4.  Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization.

Authors:  M E Harper; L M Marselle; R C Gallo; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

5.  The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes.

Authors:  T A Waldmann
Journal:  Science       Date:  1986-05-09       Impact factor: 47.728

6.  T-cell growth factor gene: lack of expression in human T-cell leukemia-lymphoma virus-infected cells.

Authors:  S K Arya; F Wong-Staal; R C Gallo
Journal:  Science       Date:  1984-03-09       Impact factor: 47.728

7.  The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells.

Authors:  H Stein; D Y Mason; J Gerdes; N O'Connor; J Wainscoat; G Pallesen; K Gatter; B Falini; G Delsol; H Lemke
Journal:  Blood       Date:  1985-10       Impact factor: 22.113

8.  Autocrine growth of interleukin 2-producing leukemic cells in a patient with adult T cell leukemia.

Authors:  N Arima; Y Daitoku; S Ohgaki; J Fukumori; H Tanaka; Y Yamamoto; K Fujimoto; K Onoue
Journal:  Blood       Date:  1986-09       Impact factor: 22.113

9.  Autocrine growth stimulation of a human T-cell lymphoma line by interleukin 2.

Authors:  V Duprez; G Lenoir; A Dautry-Varsat
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

10.  Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.

Authors:  E A Grimm; A Mazumder; H Z Zhang; S A Rosenberg
Journal:  J Exp Med       Date:  1982-06-01       Impact factor: 14.307

View more
  13 in total

1.  In situ detection of activated cytotoxic cells in follicular lymphomas.

Authors:  M B Leger-Ravet; O Devergne; M Peuchmaur; P Solal-Celigny; N Brousse; P Gaulard; P Galanaud; D Emilie
Journal:  Am J Pathol       Date:  1994-03       Impact factor: 4.307

2.  Cytokines as Adjuvants for Vaccine and Cellular Therapies for Cancer.

Authors:  Christian M Capitini; Terry J Fry; Crystal L Mackall
Journal:  Am J Immunol       Date:  2009-01-01

3.  Interleukin-12 expression is focally enhanced in the gastric mucosa of pediatric patients with Crohn's disease.

Authors:  D Berrebi; M Besnard; G Fromont-Hankard; R Paris; J F Mougenot; P De Lagausie; D Emilie; J P Cezard; J Navarro; M Peuchmaur
Journal:  Am J Pathol       Date:  1998-03       Impact factor: 4.307

4.  Cytokine expression in T-cell lymphomas and Hodgkin's disease. Its possible implication in autocrine or paracrine production as a potential basis for neoplastic growth.

Authors:  H Merz; A Fliedner; K Orscheschek; T Binder; W Sebald; H K Müller-Hermelink; A C Feller
Journal:  Am J Pathol       Date:  1991-11       Impact factor: 4.307

5.  Increased expression of perforin and granzyme B genes in patients with metastatic melanoma treated with recombinant interleukin-2.

Authors:  M B Leger-Ravet; C Mathiot; A Portier; M Brandely; P Galanaud; W H Fridman; D Emilie
Journal:  Cancer Immunol Immunother       Date:  1994-07       Impact factor: 6.968

6.  Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome.

Authors:  Q Zhang; I Nowak; E C Vonderheid; A H Rook; M E Kadin; P C Nowell; L M Shaw; M A Wasik
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

7.  Parallel interleukin 5 synthesis by eosinophils in duodenal and skin lesions of a patient with dermatitis herpetiformis.

Authors:  P Desreumaux; A Janin; E Delaporte; S Dubucquoi; F Piette; A Cortot; M Capron; J F Colombel
Journal:  Gut       Date:  1995-07       Impact factor: 23.059

8.  Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells.

Authors:  O Devergne; A Marfaing-Koka; T J Schall; M B Leger-Ravet; M Sadick; M Peuchmaur; M C Crevon; K J Kim; T T Schall; T Kim
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

9.  Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites.

Authors:  M C Dieu; B Vanbervliet; A Vicari; J M Bridon; E Oldham; S Aït-Yahia; F Brière; A Zlotnik; S Lebecque; C Caux
Journal:  J Exp Med       Date:  1998-07-20       Impact factor: 14.307

10.  Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease.

Authors:  P Desreumaux; A Janin; J F Colombel; L Prin; J Plumas; D Emilie; G Torpier; A Capron; M Capron
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.